Citigroup
MBX

Citigroup’s MBX Biosciences MBX Stock Holding History

Citigroup’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
25,122
+11,623
+86% +$406K ﹤0.01% 3211
2026
Q1 		$403K Sell
13,499
-2,892
-18% -$98.3K ﹤0.01% 3675
2025
Q4 		$517K Buy
16,391
+16,213
+9,108% +$393K ﹤0.01% 3557
2025
Q3 		$3.12K Sell
178
-5,545
-97% -$74.1K ﹤0.01% 5371
2025
Q2 		$65.3K Sell
5,723
-91,605
-94% -$933K ﹤0.01% 4629
2025
Q1 		$718K Buy
97,328
+88,464
+998% +$935K ﹤0.01% 3472
2024
Q4 		$163K Buy
+8,864
New +$189K ﹤0.01% 4537

Other funds holding MBX

AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Citigroup's MBX Position: Q2 2026 in Review

Citigroup increased its MBX Biosciences (MBX) stake by 86% in Q2 2026, buying an estimated $406K and bringing the position to 25,122 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

Citigroup first reported a position in MBX in Q4 2024 and has held it in 7 quarters since. 26 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Citigroup held 25,122 shares of MBX Biosciences worth $1.39M as of Q2 2026.
  • Citigroup bought 11,623 MBX Biosciences shares in Q2 2026, an estimated $406K.
  • MBX Biosciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3211 holding.
  • Citigroup first reported a position in MBX Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 26 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.